Modern Synthesis: First microbial materials to emerge from Modern Synthesis new patent-pending biotechnology platform

The pioneering biotechnology company, Modern Synthesis, has revealed a first look at its revolutionary new class of biomaterials made with nanocellulose. Produced at their newly opened pilot facility in London, this particularly strong and fine form of cellulose is derived from bacterial fermentation, resulting in a sustainable biotextile that is naturally animal and plastic free. The company's patent-pending biotechnology platform leverages biology, material science, and textile engineering tools to create a range of highly customisable nonwoven textiles. This new platform presents one of the biggest advances in the textile field since the industrial era, offering fashion brands the ability to reduce their ecological footprint while introducing a novel look and feel into their products. Following a successful $5.1M fundraise last year, the company built a first-of-its-kind microfactory in London, where they are able to design new biomaterials to meet industry requirements for sustainability and performance. Working directly with fashion brands to tune the materials for specific product applications from the nanoscale up, Modern Synthesis says it's the versatility of their technology which will enable them to deliver both impact and scale, without sacrificing quality or creative control. "We set out to build a holistic solution to fashion's interrelated challenges with ...